The federal government plans to propose a rule in December that would end the option allowing television and radio drug ads to send viewers to a website, phone number, or other source for a medication's full risk information instead of including it in the ad itself.
Nothing has changed yet. The plan appears on the administration's regulatory agenda as a future proposed rule. It is not in effect, it is not final, and the FDA says it is not a ban. If the proposal is published as scheduled, a public comment period will follow, and any final rule would come later.
